Prana Biotechnology (PRAN)
Add to Watchlists Create an Alert
2.39
+0.10 +4.37%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Prana Biotechnology Interest Expense
Prana Biotechnology Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
PRAN Interest Expense Benchmarks
| Companies | |
|---|---|
| DARA Biosciences | 0.00 |
| Cerus Corporation | 0.131M |
| ARCA biopharma | 0.001M |
PRAN Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 0.00 | Jun 2008 |
| Average | 0.00 |
